Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study
Authors:
- 25 October 2016
- journal article
- research article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 52 (6) , 734-745
Abstract
Procalcitonin is being increasingly used to diagnose and grade acute systemic bacterial infection at an early stage of disease onset. The aim of this prospective study was to evaluate the usefulness of procalcitonin for severity grading of acute cholangitis on patient admission.Keywords
This publication has 40 references indexed in Scilit:
- Cost-Effectiveness of Procalcitonin-Guided Antibiotic Use in Community Acquired PneumoniaJournal of General Internal Medicine, 2013
- TG13 flowchart for the management of acute cholangitis and cholecystitisJournal of Hepato-Biliary-Pancreatic Sciences, 2013
- Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and futureBMC Medicine, 2011
- Diagnostic performance of procalcitonin for bacteremia in patients with bacterial infection at the emergency departmentJournal of Infection, 2010
- Procalcitonin increase in early identification of critically ill patients at high risk of mortality*Critical Care Medicine, 2006
- Procalcitonin and the Calcitonin Gene Family of Peptides in Inflammation, Infection, and Sepsis: A Journey from Calcitonin Back to Its PrecursorsThe Journal of Clinical Endocrinology & Metabolism, 2004
- High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administrationJournal of Leukocyte Biology, 2002
- Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Fever in the ElderlyClinical Infectious Diseases, 2000
- Endoscopic Biliary Drainage for Severe Acute CholangitisNew England Journal of Medicine, 1992